Pfizer signs ground-breaking academic research deal
May 18, 2010Research and Development Pfizer, US, academia, clinical research
Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …
Bayer opens US ‘science hub’
May 18, 2010Research and Development Bayer, US, acdemia, clinical research
Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …
Merck’s Brinavess performs in phase III
May 18, 2010Research and Development Brinavess, Merck & Co, atrial fibrilation
Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …
Lansley warns of deeper NHS cuts
May 17, 2010NHS, NHS funding, election, government
Health Secretary Andrew Lansley has warned the NHS may face deeper cuts than expected. Lansley, who was appointed Health Secretary …
FDA says rotavirus vaccines are safe
May 17, 2010Manufacturing and Production drug safety, rotarix, rotateq
The US Food and Drug Administration has taken the advice of its advisors and given its backing to resume the …
New global ‘polypill’ trials start
May 17, 2010Research and Development Dr Reddy, hypertension, polypill, statin
New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …
Takeda plans cuts, eyes mergers
May 17, 2010Research and Development, Sales and Marketing Takeda, job cuts
Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …
Astellas set to acquire OSI Pharmaceuticals for $4bn
May 17, 2010Research and Development, Sales and Marketing Astellas, M&A, MA, OSI
After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …
Planning permission: Designing the systems behind successful e-marketing campaigns
May 14, 2010Medical Communications
by Kathryn Bennett, Managing Director – TVF Communications
What is Digital Marketing?
May 14, 2010Medical Communications
Some consider it just another channel to market, but the reality is more complicated.by Mark Millar, PraeMedica
Digital Pharma: No breakthrough, but UK’s digital issues out in the open
May 14, 2010Medical Communications Code of Practice, PMCPA, digi, digital, pm society
The UK’s Code of Practice regulator will produce guidance for pharma on digital marketing, but is reluctant to make formal …
Can Apple Sweeten the Taste of the Tablet?
May 14, 2010Medical Communications
by Matthew Baker, Deputy Managing Director – LEC
Developments in Digital Media
May 14, 2010Medical Communications
by David Hunt, Digital Director – Creative Lynx Ltd
Share your Brand: Go Video, Go Social
May 14, 2010Medical Communications
Stephen Dunn of London and Madrid-based Brandcast Health, suggests how you can capitalise on the video-sharing democracy of the web.
EMA readies paediatric trials network
May 14, 2010Research and Development EMA, EMEA, paediatric, paediatric trials
The European Medicines Agency is about to press the start button on its long-planned network for clinical studies in children. …
Pfizer adds another product to its PAH franchise
May 14, 2010Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra
Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …
Contract research news in brief
May 14, 2010Research and Development CRO, Clinipace, Covance, Encorium, IR Pharma, Imperial College, PPD, Parexel
Developments in the contract research sector this week include the opening of new offices for Parexel and PPD, the spin-out …
Cedra appoints Anthony Busa
May 14, 2010Research and Development CRO, Cedra, appointment, research and development
Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …
WuXi posts buoyant increases in revenue and profit
May 13, 2010Research and Development CRO, Charles River, Charles River Laboratories, WuXi
China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …
Phillipe Lutz joins Telormedix
May 13, 2010Research and Development appointment, research and development, telormedix
Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
